TAKEDA PHARMACEUTICAL CO LTD
Insider CIK 1395064 · CALA 10% owner · OVID 10% owner · CRTX 10% owner · MYOV 10% owner · TBIO 10% owner · THRX 10% owner · PHAT 10% owner · XLO 10% owner · DAWN 10% owner · HLVX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OVID Ovid Therapeutics Inc. | C Conversion deriv | 2025-12-08 | 2025-12-09 | 1,250 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | C Conversion | 2025-12-08 | 2025-12-09 | 1,250,000 | — | $0 | 7,000,000 | SEC↗ |
| HLVX HilleVax, Inc. | U Tender | 2025-09-17 | 2025-09-19 | 6,724,000 | $1.95 | $13.11M | 0 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2024-01-24 | 2024-01-25 | 3,703,703 | $8.10 | $30.00M | 3,755,583 | SEC↗ |
| CALA Calithera Biosciences, Inc | J Other deriv | 2023-04-17 | 2023-05-26 | 1,000,000 | — | $0 | 0 | SEC↗ |
| HLVX HilleVax, Inc. | X Exercise deriv | 2022-11-30 | 2022-12-01 | 5,883,500 | — | $0 | 0 | SEC↗ |
| HLVX HilleVax, Inc. | X Exercise | 2022-11-30 | 2022-12-01 | 5,883,500 | — | $0 | 6,724,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | J Other deriv | 2022-07-01 | 2022-07-06 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| CALA Calithera Biosciences, Inc | J Other deriv | 2022-07-01 | 2022-07-06 | 1,000,000 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | J Other deriv | 2022-07-01 | 2022-07-06 | 1,250 | — | $0 | 1,250 | SEC↗ |
| OVID Ovid Therapeutics Inc. | J Other deriv | 2022-07-01 | 2022-07-06 | 1,250 | — | $0 | 0 | SEC↗ |
| OVID Ovid Therapeutics Inc. | J Other | 2022-07-01 | 2022-07-06 | 5,750,000 | — | $0 | 5,750,000 | SEC↗ |
| OVID Ovid Therapeutics Inc. | J Other | 2022-07-01 | 2022-07-06 | 5,750,000 | — | $0 | 0 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | X Exercise deriv | 2022-03-14 | 2022-03-16 | 7,359,304 | — | $0 | 0 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2022-03-14 | 2022-03-16 | 18 | $19.00 | $342 | 7,459,286 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | X Exercise | 2022-03-14 | 2022-03-16 | 7,359,304 | — | $0 | 7,459,304 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2021-12-08 | 2021-12-09 | 110,338 | $18.03 | $1.99M | 6,120,124 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2021-12-07 | 2021-12-09 | 128,745 | $18.43 | $2.37M | 6,288,652 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2021-12-07 | 2021-12-09 | 58,190 | $19.50 | $1.13M | 6,230,462 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2021-12-06 | 2021-12-07 | 97,692 | $18.05 | $1.76M | 6,417,397 | SEC↗ |
| DAWN Day One Biopharmaceuticals | S Sale | 2021-12-03 | 2021-12-07 | 12,517 | $18.47 | $231.2K | 6,515,089 | SEC↗ |
| DAWN Day One Biopharmaceuticals | J Other | 2021-11-24 | 2021-11-29 | 57,224 | — | $0 | 6,527,606 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | X Exercise deriv | 2021-11-04 | 2021-11-08 | 228,696 | — | $0 | 7,359,304 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-11-04 | 2021-11-08 | 1,000,000 | $20.85 | $20.85M | 100,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | X Exercise | 2021-11-04 | 2021-11-08 | 228,696 | — | $0 | 1,100,001 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-11-04 | 2021-11-08 | 1 | $19.00 | $19 | 1,100,000 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-26 | 1,248,180 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion deriv | 2021-10-26 | 2021-10-26 | 226,941 | — | $0 | 0 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | C Conversion | 2021-10-26 | 2021-10-26 | 1,475,121 | — | $0 | 1,475,121 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion deriv | 2021-10-12 | 2021-10-15 | 1,615,427 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | C Conversion | 2021-10-12 | 2021-10-15 | 1,615,427 | — | $0 | 1,615,427 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-07-07 | 2021-07-09 | 2,609 | $35.05 | $91.4K | 871,305 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-07-02 | 2021-07-06 | 100 | $35.01 | $3.5K | 873,914 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-07-01 | 2021-07-06 | 8,226 | $35.16 | $289.2K | 874,014 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-28 | 2021-06-29 | 370 | $35.08 | $13.0K | 882,240 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-25 | 2021-06-29 | 1,250 | $36.07 | $45.1K | 882,610 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-25 | 2021-06-29 | 22,881 | $35.46 | $811.4K | 883,860 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-24 | 2021-06-25 | 10,848 | $35.14 | $381.2K | 906,741 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-23 | 2021-06-25 | 200 | $35.00 | $7.0K | 917,589 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-22 | 2021-06-23 | 100 | $35.00 | $3.5K | 917,789 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-21 | 2021-06-23 | 9,294 | $35.31 | $328.2K | 917,889 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-18 | 2021-06-21 | 5,398 | $35.13 | $189.6K | 927,183 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-17 | 2021-06-21 | 3,305 | $35.08 | $115.9K | 932,581 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-14 | 2021-06-16 | 2,826 | $35.06 | $99.1K | 935,886 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-10 | 2021-06-11 | 2,102 | $35.14 | $73.9K | 938,712 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-09 | 2021-06-11 | 1,191 | $35.28 | $42.0K | 940,814 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-08 | 2021-06-09 | 100 | $35.00 | $3.5K | 942,005 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-07 | 2021-06-09 | 2,264 | $35.05 | $79.4K | 942,105 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-02 | 2021-06-04 | 4,300 | $35.18 | $151.3K | 944,369 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-01 | 2021-06-02 | 7,244 | $35.55 | $257.5K | 952,636 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-06-01 | 2021-06-02 | 3,967 | $36.20 | $143.6K | 948,669 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-28 | 2021-06-02 | 2,668 | $36.40 | $97.1K | 961,984 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-28 | 2021-06-02 | 2,104 | $37.55 | $79.0K | 959,880 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-28 | 2021-06-02 | 4,133 | $35.37 | $146.2K | 964,652 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-27 | 2021-05-28 | 2,279 | $37.55 | $85.6K | 968,785 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-27 | 2021-05-28 | 6,174 | $36.99 | $228.4K | 971,064 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-26 | 2021-05-28 | 7,469 | $36.45 | $272.2K | 982,127 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-26 | 2021-05-28 | 4,889 | $36.92 | $180.5K | 977,238 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-25 | 2021-05-26 | 548 | $36.59 | $20.1K | 989,596 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-25 | 2021-05-26 | 10,399 | $36.16 | $376.0K | 990,144 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-24 | 2021-05-26 | 8,911 | $35.58 | $317.1K | 1,002,226 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-24 | 2021-05-26 | 1,683 | $36.10 | $60.8K | 1,000,543 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-21 | 2021-05-24 | 11,648 | $35.74 | $416.3K | 1,011,137 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-20 | 2021-05-24 | 7,098 | $35.10 | $249.1K | 1,022,785 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-14 | 2021-05-18 | 100 | $35.00 | $3.5K | 1,029,883 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-13 | 2021-05-14 | 100 | $35.33 | $3.5K | 1,029,983 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-12 | 2021-05-14 | 905 | $36.06 | $32.6K | 1,030,083 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-12 | 2021-05-14 | 10,871 | $35.39 | $384.7K | 1,030,988 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-07 | 2021-05-11 | 1,011 | $35.03 | $35.4K | 1,041,859 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-06 | 2021-05-07 | 202 | $35.01 | $7.1K | 1,042,870 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-05 | 2021-05-07 | 6,936 | $35.14 | $243.7K | 1,043,072 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-04 | 2021-05-05 | 11,070 | $35.50 | $393.0K | 1,058,298 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-04 | 2021-05-05 | 4,690 | $36.21 | $169.8K | 1,053,608 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-04 | 2021-05-05 | 3,500 | $37.47 | $131.1K | 1,050,108 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-04 | 2021-05-05 | 100 | $38.53 | $3.9K | 1,050,008 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-03 | 2021-05-05 | 203 | $39.06 | $7.9K | 1,069,368 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-03 | 2021-05-05 | 11,272 | $38.45 | $433.4K | 1,069,571 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | S Sale | 2021-05-03 | 2021-05-05 | 3,157 | $37.60 | $118.7K | 1,080,843 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-06-30 | 2020-06-30 | 6,824,992 | $20.68 | $141.14M | 0 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-06-03 | 2020-06-05 | 40,086 | $19.75 | $791.7K | 6,824,992 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-06-02 | 2020-06-03 | 5,006 | $20.02 | $100.2K | 6,865,078 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-06-02 | 2020-06-03 | 100,389 | $19.75 | $1.98M | 6,870,084 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-06-01 | 2020-06-03 | 1,400 | $20.53 | $28.7K | 6,970,473 | SEC↗ |
| TBIO Translate Bio, Inc. | S Sale | 2020-06-01 | 2020-06-03 | 107,072 | $19.85 | $2.13M | 6,971,873 | SEC↗ |
| OVID Ovid Therapeutics Inc. | P Buy | 2019-10-08 | 2019-11-22 | 2,000,000 | $2.50 | $5.00M | 5,750,000 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 2,360,071 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-13 | 319,731 | — | $0 | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | C Conversion | 2019-05-13 | 2019-05-13 | 2,679,802 | — | $0 | 2,679,802 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2018-03-19 | 2018-03-21 | 7,420,625 | $18.67 | $138.54M | 7,420,625 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2018-03-19 | 2018-03-21 | 7,420,625 | $18.67 | $138.54M | 0 | SEC↗ |